The verdict is in:

"A Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males."

Why is this important? Because it exposes a number of facts about corporate giant J&J:

- J&J hid the risks of gynecomastia from happening in recent years
- J&J paid $2.2 billion two years ago to resolve criminal and civil allegations of illegally marketing the drug
- J&J failed to disclose data showing the extent to which youngsters may develop gynecomastia
- J&J says there are about 1,200 such lawsuits filed in courts around the country

J&J is still arguing that things were properly labeled, and it's not their fault it was being incorrectly marketed, but most of the evidence is against them.